Verve Therapeutics所有資訊

Verve Therapeutics | 4：持股變動聲明-高管 Ashe Andrew D.

05/15 17:31 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Nickerson Joan

04/03 17:05 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Ashe Andrew D.

02/16 16:34 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Kathiresan Sekar

02/16 16:32 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Nickerson Joan

02/16 16:32 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Fiedorek Fred T.

02/16 16:32 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Dorval Allison

02/16 16:32 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Bellinger Andrew

02/16 16:32 (美東)

Verve Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(6.81%)

02/13 22:30 (美東)

Verve Therapeutics | 5：權益變更年度報表-董事 ADELMAN BURT A

02/09 17:07 (美東)

Verve Therapeutics | SC 13G：超過5%持股股東披露文件-BlackRock, Inc.(5.6%)

01/29 17:34 (美東)

Verve Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-ARK Investment Management LLC(8.74%)

01/29 16:04 (美東)

Verve Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(4.81%)

01/23 00:00 (美東)

Verve Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-XXVI Holdings Inc.(15.4%),Alphabet Inc.(15.4%)等

2023/12/11 16:16 (美東)

Verve Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-FMR LLC(4.842%),Abigail P. Johnson(4.842%)

2023/12/11 09:09 (美東)

Verve Therapeutics | 3：首次持股聲明-其他相關方 GV 2023 GP, L.L.C.

2023/12/05 16:50 (美東)

Verve Therapeutics | 4：持股變動聲明-董事 Yeshwant Krishna

2023/12/05 16:30 (美東)

Verve Therapeutics | 4：持股變動聲明-首席財務官 Dorval Allison

2023/12/01 16:30 (美東)

Verve Therapeutics | 4：持股變動聲明-高管 Fiedorek Fred T.

2023/09/19 17:05 (美東)

Verve Therapeutics | 3：首次持股聲明-高管 Fiedorek Fred T.

2023/09/19 17:00 (美東)